Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro studies of cell-mediated immunity. I. Induction of lymphocyte transformation by a soluble "mitogenic" factor derived from interaction of sensitized guinea-pig lymphoid cells with specific antigen.

× No keyword cloud information.

15 in total

Review 1. The role of the macrophage in delayed hypersensitivity.

Authors: D C Dumonde
Journal: Br Med Bull Date: 1967-01 Impact factor: 4.291

2. Lymphocyte cytotoxicity in vitro: activation and release of a cytotoxic factor.

Authors: G A Granger; T W Williams
Journal: Nature Date: 1968-06-29 Impact factor: 49.962

3. Cell migration inhibition factor released by antigen from human peripheral lymphocytes.

Authors: D E Thor; R E Jureziz; S R Veach; E Miller; S Dray
Journal: Nature Date: 1968-08-17 Impact factor: 49.962

4. Reactions in vivo and in vitro produced by a soluble substance associated with delayed-type hypersensitivity.

Authors: B Bennett; B R Bloom
Journal: Proc Natl Acad Sci U S A Date: 1968-03 Impact factor: 11.205

5. Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin.

Authors: W P Kolb; G A Granger
Journal: Proc Natl Acad Sci U S A Date: 1968-12 Impact factor: 11.205

6. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.

Authors: J R David
Journal: Proc Natl Acad Sci U S A Date: 1966-07 Impact factor: 11.205

7. A factor stimulating DNA synthesis derived from the medium of leukocyte cultures.

Authors: S Kasakura; L Lowenstein
Journal: Nature Date: 1965-11-20 Impact factor: 49.962

8. Delayed hypersensitivity in the guinea-pig to a protein-hapten conjugate and its relationship to in vitro transformation of lymph node, spleen, thymus and peripheral blood lymphocytes.

Authors: J J Oppenheim; R A Wolstencroft; P G Gell
Journal: Immunology Date: 1967-01 Impact factor: 7.397

9. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

Authors: B R Bloom; B Bennett
Journal: Science Date: 1966-07-01 Impact factor: 47.728

10. Sequential changes in the relative affinity of antibodies synthesized during the immune response.

Authors: L A Steiner; H N Eisen
Journal: J Exp Med Date: 1967-12-01 Impact factor: 14.307

14 in total

1. Mediation of macrophage effector function by lymphokine.

Authors: L W Poulter; J L Turk
Journal: Agents Actions Date: 1976-02

2. Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation.

Authors: R H Kelly; R A Wolstencroft; D C Dumonde; B M Balfour
Journal: Clin Exp Immunol Date: 1972-01 Impact factor: 4.330

3. Role of lymphocyte activation products (LAP) in cell-mediated immunity. I. Preparation and partial purification of guinea-pig LAP.

Authors: D C Dumonde; D A Page; M Matthew; R A Wolstencroft
Journal: Clin Exp Immunol Date: 1972-01 Impact factor: 4.330

4. Possible relationships between antibodies and non-specific immunoglobulins simultaneously induced after antigenic stimulation.

Authors: C De Vos-Cloetens; V Minsart-Baleriaux; G Urbain-Vansanten
Journal: Immunology Date: 1971-06 Impact factor: 7.397

5. Lymphocyte transformation in chronic renal failure.

Authors: L S Nakhla; M J Goggin
Journal: Immunology Date: 1973-02 Impact factor: 7.397

6. Lymphocyte activation. II. Kinetics and specificity of the activation process with phytohaemagglutinin and concanavalin A.

Authors: G Jones
Journal: Clin Exp Immunol Date: 1972-11 Impact factor: 4.330

7. The production of lymphocyte mitogenic factor and migration-inhibition factor by antigen-stimulated lymphocytes of subjects with grass pollen allergy.

Authors: R N Maini; D C Dumonde; J A Faux; F E Hargreave; J Pepys
Journal: Clin Exp Immunol Date: 1971-10 Impact factor: 4.330

In vitro studies of cell-mediated immunity. I. Induction of lymphocyte transformation by a soluble "mitogenic" factor derived from interaction of sensitized guinea-pig lymphoid cells with specific antigen.